期刊
RSC ADVANCES
卷 12, 期 2, 页码 1062-1076出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d1ra07499g
关键词
-
资金
- Natural Science Foundation of Shanghai [20ZR1413600]
- National Natural Science Foundation of China [21576080]
The transformation of gliclazide (GLI) into an ionic liquid showed improved solubility, supersaturation ratio, and duration of supersaturation, enhancing its potential for oral absorption. Computational methodology was employed to understand the increased solubility results, indicating less stable ion pairs of the prepared IL in an aqueous environment. Furthermore, the prepared oral capsules containing GLI-based IL loaded mesoporous silica particles exhibited fast release with 100% release achieved within 60 minutes.
Ionic liquid (IL) technology provides a useful platform to enhance the oral absorption of therapeutic agents. In the present work, gliclazide (GLI), a second-generation sulfonylurea drug was transformed into an IL with tetrabutylphosphonium. The physicochemical properties of this IL were systematically characterized by DSC, TGA, FT-IR, NMR, and HPLC. For the further preparation development, a solution stability test was conducted. GLI-based IL could improve the solution stability in a neutral environment. To assess oral potential, the solubility characteristics including equilibrium solubility, 24 h kinetic saturation solubilities and supersaturation profiles were first explored. Significant enhancement of solubilities, supersaturation ratio and duration of supersaturation was found for the synthesized IL. Computational methodology was utilized to better understand the improved solubility results. From the simulated results, [TBP][GLI] showed a longer time period when the distance between cation and anion was far above the baseline and a higher deviation degree, indicating less stable ion pairs of [TBP][GLI] in an aqueous environment and it being easy for the cation and anion to tear apart and form interactions with water molecules. The prepared [TBP][GLI] exhibited intestinal transportation ability and safety as evidenced by the in vitro gastrointestinal tract artificial membrane permeability assays (GIT-PAMPA) and cytotoxicity experiments with Caco-2 cells. A mesoporous carrier, AEROPERL (R) 300 Pharma, was chosen to load the IL and then encapsuled into enteric capsules. The prepared oral capsules containing GLI-based IL loaded mesoporous silica particles released fast and could realize 100% release within 60 min.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据